Trial Profile
Phase II study of gefitinib and docetaxel as salvage therapy in advanced pancreatic carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Gefitinib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 28 Nov 2005 New trial record.